For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
Market-oriented reforms that can save Medicare $100 billion
Since 1970, Medicare spending has grown from 0.7 percent of GDP to 4.0 percent of GDP, and it is projected to grow even further.
Blog
This week in health care policy: October 16–23, 2026
Medical innovation FDA approves several innovative treatments. Last week, the FDA granted accelerated approval to GSK’s Jemperli for certain untreated…
Blog
This week in health care policy: October 8–15, 2026
Innovation watch Merck expects faster production of its personalized cancer vaccine. CEO Rob Davis told CNBC the six-week turnaround for…
Search Posts
Washington Examiner
The Biden administration shouldn’t waste more taxpayer dollars on COVID vaccines
A Food and Drug Administration advisory committee recently voted to recommend updating the COVID-19 vaccine. But important questions remain:…
Letters
CEI Joins Coalition Letter Supporting Efforts to Stop Tobacco Prohibitions in Ag Approps Bill
Chairwoman Granger and Ranking Member DeLauro, The undersigned organizations representing millions of consumers and taxpayers support Sections 768 and 769 of the Fiscal…
National Review
Pharmaceuticals: Marching into Trouble
The National Institutes of Health recently rejected a request by private petitioners to exercise “march-in rights” under the 1980 Bayh-Dole Act to control…
City Journal
Nature’s Vaccine
Public-health officials in the U.S., unlike their counterparts elsewhere, have steadfastly focused on Covid-19 vaccines in fighting the pandemic, acting as if natural immunity…
Washington Examiner
Under Walensky, the CDC has destroyed public trust in its credibility
The White House announced last week that Dr. Rochelle Walensky will be leaving her post as director of the Centers for Disease Control and Prevention.
Wall Street Journal
Don’t Let Unspent Covid Funds Become Slush Funds
The House has passed the Limit, Save, Grow Act, which would raise the debt limit for a year in exchange for deficit-relief measures. One…